Answers are grounded in this paper and cite their sources.
Benefits of Phase 1 Oncology Trials Historically, phase 1 trials have been aimed at defining the toxic effects of an agent. With the advent of targeted therapies and immunotherapies, response rates...
No takes yet. Share an insight, caveat, or question.
Chakiba et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: